Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002
21 nov. 2019 08h00 HE
|
Bio-Path Holdings, Inc.
HOUSTON, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a...